Anti-erythroblast antibodies and defective apoptosis in bone marrow of early myelodysplastic syndrome patients.

被引：0
|
作者：
Zaninoni, A [1 ]
Imperiali, FG [1 ]
Fermo, E [1 ]
Zanella, A [1 ]
Barcellini, W [1 ]
机构：
[1] Osped Maggiore, IRCCS, Policlin Milano, Dept Hematol, I-20122 Milan, Italy
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4705
引用
收藏
页码：260B / 260B
页数：1
相关论文
共 50 条
  • [1] Anti-erythroblast autoimmunity in early myelodysplastic syndromes
    Barcellini, Wilma
    Zaninoni, Anna
    Imperiali, Francesca G.
    Boschetti, Carla
    Colombi, Mariangela
    Iurlo, Alessandra
    Zanella, Alberto
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 19 - 26
  • [2] Apoptosis in bone marrow of myelodysplastic syndrome patients
    Bogdanovic, AD
    Jankovic, GM
    Colovic, MD
    Trpinac, DP
    Bumbasirevic, VZ
    BLOOD, 1996, 87 (07) : 3064 - 3064
  • [3] Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes
    Zaninoni, Anna
    Imperiali, Francesca G.
    Cattaneo, Alessandra
    Soverini, Giulia
    Binda, Francesca
    Porretti, Laura
    Cortelezzi, Agostino
    Barcellini, Wilma
    TRANSFUSION, 2016, 56 (08) : 2037 - 2041
  • [4] Research of subset and function of th cells in bone marrow of myelodysplastic syndrome patients.
    Wang, XL
    Wu, DP
    He, GS
    Miao, M
    Sun, AN
    BLOOD, 2005, 106 (11) : 308B - 308B
  • [5] Thalidomide significantly modifies bone marrow microenvironment in myelodysplastic syndrome (MDS) patients.
    Alvi, S
    Borok, RZ
    Shaher, A
    Anthwal, S
    Shaikh, M
    Alvi, I
    Tahir, S
    John, P
    Shetty, V
    Galili, N
    Raza, A
    BLOOD, 2002, 100 (11) : 375A - 375A
  • [6] ANTI-ERYTHROBLAST AUTOIMMUNITY IN EARLY MYELODYSPLASTIC SYNDROMES: ENHANCEMENT OF EPO/EPO-R SYSTEM AND PRO-APOPTOTIC EFFECT
    Zaninoni, A.
    Imperiali, F. G.
    Cattaneo, A.
    Fattizzo, B.
    Cortelezzi, A.
    Porretti, L.
    Zanella, A.
    Barcellini, W.
    HAEMATOLOGICA, 2014, 99 : 83 - 83
  • [7] A novel retinoid in bone marrow and plasma from control subjects and myelodysplastic syndrome patients.
    Besa, EC
    Rubin, S
    Canova, A
    Caputo, C
    Connolly, MM
    Piantedosi, R
    Blaner, W
    BLOOD, 1997, 90 (10) : 4030 - 4030
  • [8] Long-term bone marrow culture profiles in patients with myelodysplastic syndromes are not explicable by defective apoptosis
    McMullin, MF
    Buckley, O
    Magill, MK
    Irvine, AE
    LEUKEMIA RESEARCH, 1998, 22 (08) : 735 - 740
  • [9] Ultrastructural evidence of previously unreported excessive apoptosis in high density bone marrow (BM) cells of myelodysplastic syndrome (MDS) patients.
    Shetty, V
    Hussaini, S
    Broady-Robinson, L
    Allampallam, K
    Ansaari, I
    Holtzclaw, J
    Mundle, S
    Mazzoran, L
    Zorat, F
    Payne, C
    Raza, A
    BLOOD, 1999, 94 (10) : 287B - 287B
  • [10] Long-term bone marrow culture profiles in patients with myelodysplastic syndromes are not explicable by defective apoptosis.
    McMullin, MF
    Buckley, O
    Magill, MK
    Irvine, AE
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 452 - 452
12345